Yearly Archives: 2022
Merit Medical Launches Smallest and Shortest Configuration of Elation® Pulmonary Balloon Dilator to Help Meet Critical Patient Need
Only balloon configuration specifically designed to dilate small airways, providing minimally invasive treatment to patients with lung obstructions
Co-Diagnostics, Inc. to Announce Expansion of OEM Agreement with Bio Molecular Systems at AACC
Co-Diagnostics announced that it will be disclosing the global expansion of its OEM agreement with Bio Molecular Systems (BMS) at the Company’s customer and distributor update today at AACC.
ARUP’s New Monkeypox Test Can Be Performed on More Specimen Types on High-Throughput Instruments
SALT LAKE CITY, July 25, 2022 — ARUP Laboratories today announced that it has begun in-house testing for monkeypox. The Orthopoxvirus (includes monkeypox virus) by PCR test (test code 3005716) is a real-time polymerase chain reaction (RT-PCR) test to detect the DNA of orthopoxviruses, including monkeypox. ARUP’s test is similar to the CDC assay that […]
BD Completes Acquisition of Parata Systems
BD (Becton, Dickinson and Company) (NYSE: BDX) today announced it has completed the acquisition of Parata Systems. Parata advances BD’s transformative solutions strategy by providing a portfolio of innovative pharmacy automation solutions that power a growing network of pharmacies to reduce costs, enhance patient safety and improve the patient experience for retail, hospital and long-term care […]
BioUtah Joins State BIOs in Opposing Drug Price Controls
Senate Democrats are inching closer to a vote on a revived “Build Back Better” package, largely focused on drug pricing. The package would give Medicare the authority to negotiate drug prices and impose inflation rebates. The negotiation process, in practice, would function more like government price controls since drug manufacturers deemed non-compliant with the requirements […]
Nexus Spine Announces Launch of Stable-C™ Cervical Interbody System with Integrated Fixation
Launch represents the company’s eighth commercial release within its line of Tranquil™ interbody fusion implants
Nomi Health Opens Infant and Pediatric COVID Vaccine Location
OREM, Utah–(BUSINESS WIRE)–Nomi Health, a direct healthcare company dedicated to improving access and lowering costs in the healthcare system, today opened their first location for infant and pediatric COVID vaccine services at West Valley City Centennial Park. To ensure the safest and most positive experience, each Nomi Health employee on site has completed extensive pediatric […]
Nomi Health Acquires Everyone Health, Sano Surgery
As Americans continue to pay more for needed medical treatments and with care costs outpacing the rate of inflation, Nomi Health — the direct healthcare company making it easier than ever to access the highest quality affordable care across the U.S.— today announced two acquisitions to bolster its support of buyers of care and their […]
Co-Diagnostics, Inc. Announces Shipment of Monkeypox Virus Test
Co-Diagnostics announced that it has shipped testing reagents for monkeypox virus currently exhibiting a multi-country outbreak to one of its international distributors.
Biomerics Launches Interventional Medical Plastics Division with Acquisition of Dependable Plastics
Biomerics announced the acquisition of Dependable Plastics and creation of a new division — Biomerics Interventional Medical Plastics (IMP) Division.
Senate Democrats Renew Plan for Drug Price Controls
Senate Democrats have renewed a push for drug pricing reforms, releasing on Wednesday proposed legislation along with a bill summary.
Sumitomo Pharma Oncology Receives Orphan Drug Designation for TP-3654, an Investigational Oral Inhibitor of PIM Kinases for the Treatment of Myelofibrosis
Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, recently announced that the FDA granted Orphan Drug Designation for TP-3654, the company’s proprietary investigational oral inhibitor of PIM kinases, for the treatment of myelofibrosis. “This designation is an important milestone in the development of TP-3654 and highlights the need for potential new treatment […]
